We use cookies to make your experience better. To comply with the new e-Privacy directive, we need to ask for your consent to set the cookies. Learn more.
Share this :
Print
Genscript MonoRab™ Anti-Nivolumab Antibody (40F11), mAb, Rabbit
Genscript MonoRab™ Anti-Nivolumab Antibody (40F11), mAb, Rabbit - GSCRPT (Additional S&H or Hazmat Fees May Apply)
List Price
$205.00
Your Price
$205.00
HOW MUCH YOU SAVE:
0.00 %
| NETA PART: | GSCRPT-A01988-40 |
| MFG.PART: | A01988-40 |
| UNSPSC: | 12352203 |
| Manufacturer: | GenScript USA Inc |
Overview
| Specificity | The antibody is recommended as a detection antibody in a pharmacokinetic (PK) bridging assay with capture antibody GenScript, A01987-40, MonoRab Anti-Nivolumab Antibody (33H4), mAb, Rabbit. |
| Host Species | Rabbit |
| Immunogen | Nivolumab |
| Conjugate | Unconjugated |
Applications
| Working concentrations for specific applications should be determined by the investigators. The appropriate concentrations may be affected by secondary antibody affinity, antigen concentration, the sensitivity of the method of detection, temperature, the length of the incubations, and other factors. The suitability of this antibody for applications other than those listed below has not been determined. The following concentration ranges are recommended starting points for this product. | |||||
| |||||
Properties
| Form | Lyophilized |
| Storage Buffer | Lyophilized with PBS, pH 7.4, containing 0.02% sodium azide. |
| Reconstitution | Reconstitute the lyophilized powder with deionized water (or equivalent) to a final concentration of 0.5 mg/ml. |
| Storage Instructions | The lyophilized product remains stable up to 1 year at -20 °C from date of receipt. Upon reconstitution, it can be stored for 2-3 weeks at 2-8 °C or for up to 12 months at -20 °C or below. Avoid repeated freezing and thawing cycles. |
| Purification | Protein A affinity column |
| Isotype | Rabbit IgG |
| Clonality | Monoclonal |
| Clone ID | 40F11 |
| Note | GenScript can customize this product per customers request including product size, buffer components, etc. |
Background
| Target Background | Nivolumab is a fully human monoclonal IgG4 antibody that is approved by the U.S. Food and Drug Administration for the treatment of bladder cancer. It binds to the programmed cell death protein 1 (PD-1) on the surface of activated T cells. Nivolumab functions as PD-1 inhibitor for targeted immunotherapy.GenScript MonoRab™ Anti-Nivolumab Antibody (40F11), mAb, Rabbit is produced from a hybridoma resulting from the fusion of partner and B-lymphocytes obtained from a rabbit immunized with Nivolumab. |
| Synonyms | Rabbit monoclonal to Opdivo |
For laboratory research use only. Direct human use, including taking orally and injection and clinical use are forbidden.
| SKU | GSCRPT-A01988-40 |
|---|---|
| Supplier Part Number | A01988-40 |
| UM | EA |
| UNSPSC | 12352203 |
| Manufacturer | GenScript USA Inc |
| ProductLine | GSCRPT |
| Qty | 40 |
| MinOrderQty | 1 |
| Weight | 7.00 |
| Lead Time | 7 Business Days |
| Hazardous | N |